Felix Luessi

6.6k total citations
56 papers, 1.2k citations indexed

About

Felix Luessi is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Felix Luessi has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 21 papers in Immunology and 16 papers in Neurology. Recurrent topics in Felix Luessi's work include Multiple Sclerosis Research Studies (23 papers), T-cell and B-cell Immunology (12 papers) and Peripheral Neuropathies and Disorders (10 papers). Felix Luessi is often cited by papers focused on Multiple Sclerosis Research Studies (23 papers), T-cell and B-cell Immunology (12 papers) and Peripheral Neuropathies and Disorders (10 papers). Felix Luessi collaborates with scholars based in Germany, Moldova and Switzerland. Felix Luessi's co-authors include Frauke Zipp, Volker Siffrin, Stefan Bittner, Vinzenz Fleischer, Helmut Jonuleit, Ayman Rezk, Amit Bar‐Or, Sinah Engel, Sergiu Groppa and Jack P. Antel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Felix Luessi

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felix Luessi Germany 21 521 390 245 232 190 56 1.2k
Jeppe Romme Christensen Denmark 20 750 1.4× 429 1.1× 293 1.2× 253 1.1× 217 1.1× 50 1.4k
Tilman Schneider‐Hohendorf Germany 23 484 0.9× 662 1.7× 179 0.7× 260 1.1× 461 2.4× 40 1.6k
Kurt‐Wolfram Sühs Germany 25 574 1.1× 163 0.4× 462 1.9× 366 1.6× 197 1.0× 77 1.6k
Ludwig Kappos Switzerland 17 973 1.9× 176 0.5× 479 2.0× 235 1.0× 346 1.8× 59 1.6k
E. Sindern Germany 20 437 0.8× 307 0.8× 287 1.2× 173 0.7× 131 0.7× 46 1.1k
Helena S. Domingues Portugal 13 315 0.6× 406 1.0× 91 0.4× 329 1.4× 121 0.6× 17 1.2k
Avertano Noronha United States 17 562 1.1× 537 1.4× 202 0.8× 202 0.9× 271 1.4× 32 1.3k
Tobias Zrzavy Austria 15 855 1.6× 431 1.1× 368 1.5× 370 1.6× 104 0.5× 48 1.7k
Yukio Takeshita Japan 20 299 0.6× 215 0.6× 299 1.2× 368 1.6× 81 0.4× 49 1.2k
Alessio Bratina Italy 18 809 1.6× 129 0.3× 247 1.0× 97 0.4× 145 0.8× 38 1.1k

Countries citing papers authored by Felix Luessi

Since Specialization
Citations

This map shows the geographic impact of Felix Luessi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Luessi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Luessi more than expected).

Fields of papers citing papers by Felix Luessi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Luessi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Luessi. The network helps show where Felix Luessi may publish in the future.

Co-authorship network of co-authors of Felix Luessi

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Luessi. A scholar is included among the top collaborators of Felix Luessi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Luessi. Felix Luessi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pape, Katrin, Falk Steffen, Sinah Engel, et al.. (2025). Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis. Brain. 149(1). 123–133.
2.
Luessi, Felix, et al.. (2025). Venlafaxine-induced serotonin syndrome causing bilateral cerebral strokes: a case report. PubMed. 3. 1529674–1529674.
3.
Luessi, Felix, et al.. (2025). Atypical adverse events in a real-world study of long-term immunomodulation for multiple sclerosis and neuromyelitis optica spectrum disorder. Therapeutic Advances in Neurological Disorders. 18. 4243601294–4243601294.
4.
Engel, Sinah, Erik Ellwardt, Timo Uphaus, et al.. (2023). Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension. Fluids and Barriers of the CNS. 20(1). 3–3. 7 indexed citations
5.
6.
Zevallos, Victor F., Nir Yogev, Judith Hauptmann, et al.. (2023). Dietary wheat amylase trypsin inhibitors exacerbate CNS inflammation in experimental multiple sclerosis. Gut. 73(1). 92–104. 7 indexed citations
7.
Brahmer, Alexandra, Elmo W. I. Neuberger, Theophilos Tzaridis, et al.. (2023). Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles. Cell Communication and Signaling. 21(1). 276–276. 12 indexed citations
8.
Gairing, Simon Johannes, Leonard Kaps, Michael Nagel, et al.. (2023). Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis. JHEP Reports. 5(4). 100671–100671. 7 indexed citations
9.
Ciolac, Dumitru, Gabriel González‐Escamilla, Yaroslav Winter, et al.. (2022). Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis. European Journal of Neurology. 29(8). 2309–2320. 5 indexed citations
10.
Teegen, Bianca, Felix Luessi, W. Stöcker, et al.. (2022). Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjects. Brain Behavior and Immunity. 108. 135–147. 19 indexed citations
11.
Fleischer, Vinzenz, Muthuraman Muthuraman, Abdul Rauf Anwar, et al.. (2020). Continuous reorganization of cortical information flow in multiple sclerosis: A longitudinal fMRI effective connectivity study. Scientific Reports. 10(1). 806–806. 15 indexed citations
12.
Schwarting, Andreas, Konstantinos Triantafyllias, Simone Cosima Boedecker-Lips, et al.. (2019). Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies. Annals of the Rheumatic Diseases. 78(9). 1226–1234. 21 indexed citations
13.
Voglis, Stefanos, Sonja Moos, Florian Wanke, et al.. (2018). Regulation of IL-22BP in psoriasis. Scientific Reports. 8(1). 5085–5085. 23 indexed citations
14.
Luessi, Felix, Sinah Engel, Annette Spreer, Stefan Bittner, & Frauke Zipp. (2018). GFAPα IgG-associated encephalitis upon daclizumab treatment of MS. Neurology Neuroimmunology & Neuroinflammation. 5(5). e481–e481. 37 indexed citations
15.
Hess, Moritz, Matthias Klein, Felix Luessi, et al.. (2016). Increase of Alternatively Activated Antigen Presenting Cells in Active Experimental Autoimmune Encephalomyelitis. Journal of Neuroimmune Pharmacology. 11(4). 721–732. 11 indexed citations
16.
Muthuraman, Muthuraman, Vinzenz Fleischer, Pierre Kolber, et al.. (2016). Structural Brain Network Characteristics Can Differentiate CIS from Early RRMS. Frontiers in Neuroscience. 10. 14–14. 62 indexed citations
17.
Luessi, Felix, Bettina Trinschek, Mario Hubo, et al.. (2013). Cladribine exerts an immunomodulatory effect on human and murine dendritic cells. International Immunopharmacology. 18(2). 347–357. 26 indexed citations
18.
Luessi, Felix, Volker Siffrin, & Frauke Zipp. (2012). Neurodegeneration in multiple sclerosis: novel treatment strategies. Expert Review of Neurotherapeutics. 12(9). 1061–1077. 68 indexed citations
19.
Luessi, Felix, Michael Torzewski, Harald D. Müller, et al.. (2009). Eosinophilic Meningitis due toAngiostrongylus cantonensisin Germany. Journal of Travel Medicine. 16(4). 292–294. 32 indexed citations
20.
Ittner, Lars M., Felix Luessi, Daniela Koller, et al.. (2004). Aspartate69 of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2. Biochemical and Biophysical Research Communications. 319(4). 1203–1209. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeppe Romme Christensen Breakdown of academic impact, for papers by Tilman Schneider‐Hohendorf Breakdown of academic impact, for papers by Kurt‐Wolfram Sühs Breakdown of academic impact, for papers by Ludwig Kappos Breakdown of academic impact, for papers by E. Sindern Breakdown of academic impact, for papers by Helena S. Domingues Breakdown of academic impact, for papers by Avertano Noronha Breakdown of academic impact, for papers by Tobias Zrzavy Breakdown of academic impact, for papers by Yukio Takeshita Breakdown of academic impact, for papers by Alessio Bratina
Rankless by CCL
2026